SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_C_Subject_08 | 3 | Human | HLA-A02_01,HLA-A03_01,HLA-B07_02,HLA-C07_02 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_CELG_Subject_11 | 3 | Human | HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_J_Subject_09 | 6 | Human | HLA-A02_01,HLA-A03_01,HLA-B07_02,HLA-C07_02 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_MA_Subject_03 | 3 | Human | HLA-A02_01,HLA-A29_02,HLA-B57_01,HLA-B44_03,HLA-C07_01,HLA-C16_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_PF1_Subject_04 | 3 | Human | HLA-A02_01,HLA-A01_01,HLA-B07_02,HLA-B44_03,HLA-C07_02,HLA-C16_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_RT_Subject_10 | 3 | Human | HLA-A02_01,HLA-A01_01,HLA-B18_01,HLA-B39_24,HLA-C05_01,HLA-C07_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_PF1_Subject_04 | 1 | Human | HLA-A02_01,HLA-A01_01,HLA-B07_02,HLA-B44_03,HLA-C07_02,HLA-C16_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_RT_Subject_10 | 1 | Human | HLA-A02_01,HLA-A01_01,HLA-B18_01,HLA-B39_24,HLA-C05_01,HLA-C07_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_01 | 3 | Human | HLA-A03_01,HLA-A29_02,HLA-B08_01,HLA-B44_03,HLA-C07_01,HLA-C16_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_02 | 3 | Human | HLA-A03_01,HLA-A29_02,HLA-B08_01,HLA-B44_03,HLA-C07_01,HLA-C16_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 | 15 | Human | HLA-A02_01,HLA-A29_02,HLA-B57_01,HLA-B44_03,HLA-C07_01,HLA-C16_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 | 19 | Human | HLA-A02_01,HLA-A01_01,HLA-B07_02,HLA-B44_03,HLA-C07_02,HLA-C16_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_05 | 7 | Human | HLA-A03_01,HLA-A11_01,HLA-B44_03,HLA-B50_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_06 | 6 | Human | HLA-A02_01,HLA-A11_01,HLA-B40_01,HLA-B44_03,HLA-C03_01,HLA-C16_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 | 9 | Human | HLA-A02_01,HLA-A23_01,HLA-B18_01,HLA-B44_03,HLA-C04_01,HLA-C07_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_08 | 20 | Human | HLA-A02_01,HLA-A03_01,HLA-B07_02,HLA-C07_02 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_09 | 20 | Human | HLA-A02_01,HLA-A03_01,HLA-B07_02,HLA-C07_02 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_10 | 19 | Human | HLA-A02_01,HLA-A01_01,HLA-B18_01,HLA-B39_24,HLA-C05_01,HLA-C07_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 | 20 | Human | HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_12 | 3 | Human | HLA-A02_01,HLA-B13_02,HLA-B41_01,HLA-C06_02,HLA-C17_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_13 | 3 | Human | HLA-A02_01,HLA-A11_01,HLA-B27_05,HLA-B56_01,HLA-C01_02,HLA-C02_02 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_14 | 4 | Human | HLA-A03_01,HLA-A32_01,HLA-B27_05,HLA-B45_01,HLA-C01_02,HLA-C16_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_15 | 9 | Human | HLA-A01_01,HLA-A32_01,HLA-B08_01,HLA-C07_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_16 | 3 | Human | HLA-A11_01,HLA-B14_02,HLA-B44_02,HLA-C05_01,HLA-C08_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_17 | 3 | Human | HLA-A11_01,HLA-B18_03,HLA-B35_01,HLA-C04_01,HLA-C07_01 | ||
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_18 | 3 | Human | HLA-A03_01,HLA-A24_02,HLA-B07_02,HLA-B27_05 |
SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 | SYSMHC00010_MA_rep3_021213_Fx600mM.raw | In vitro | suspension | EBV transformed | class I | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 1 | ||||||||
SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 | SYSMHC00010_MA_rep4_021213_Fx100mM.raw | In vitro | suspension | EBV transformed | class I | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 2 | ||||||||
SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 | SYSMHC00010_MA_rep3_021213_Fx75mM.raw | In vitro | suspension | EBV transformed | class I | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 3 | ||||||||
SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 | SYSMHC00010_MA_rep4_021213_Fx600mM.raw | In vitro | suspension | EBV transformed | class I | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 4 | ||||||||
SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 | SYSMHC00010_MA_rep3_021213_Fx50mM.raw | In vitro | suspension | EBV transformed | class I | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 5 | ||||||||
SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 | SYSMHC00010_MA_rep3_021213_Fx300mM.raw | In vitro | suspension | EBV transformed | class I | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 6 | ||||||||
SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 | SYSMHC00010_MA_rep3_021213_Fx100mM.raw | In vitro | suspension | EBV transformed | class I | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 7 | ||||||||
SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 | SYSMHC00010_MA_rep4_021213_Fx75mM.raw | In vitro | suspension | EBV transformed | class I | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 8 | ||||||||
SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 | SYSMHC00010_MA_rep5_021213_Fx100mM.raw | In vitro | suspension | EBV transformed | class I | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 9 | ||||||||
SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 | SYSMHC00010_MA_rep5_021213_Fx300mM.raw | In vitro | suspension | EBV transformed | class I | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 10 | ||||||||
SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 | SYSMHC00010_MA_rep5_021213_Fx50mM.raw | In vitro | suspension | EBV transformed | class I | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 11 | ||||||||
SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 | SYSMHC00010_MA_rep5_021213_Fx600mM.raw | In vitro | suspension | EBV transformed | class I | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 12 | ||||||||
SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 | SYSMHC00010_MA_rep5_021213_Fx75mM.raw | In vitro | suspension | EBV transformed | class I | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 13 | ||||||||
SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 | SYSMHC00010_MA_rep4_021213_Fx300mM.raw | In vitro | suspension | EBV transformed | class I | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 14 | ||||||||
SYSMHC00010 | SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 | SYSMHC00010_MA_rep4_021213_Fx50mM.raw | In vitro | suspension | EBV transformed | class I | 26857467 | native | Mild acid elution | Orbitrap Elite | no | DDA | CID | 5-40% | 56 | 15 |